drugset / Trial / NCT02260492
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
RandomizedParallel-groupQuadruple-blindOther
Summary
This is a study to establish the equivalence of OT329 Solis and Advair Diskus when administered by inhalation in patients with asthma.
Timeline
- Start
- 2014-09
- Primary completion
- 2015-05
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 100 ug | Inhaled |
| Subject | salmeterol xinafoate | Unknown | 50 ug | Inhaled |